Amicus Finally Wins FDA Nod, Will Price Fabry Drug Below Rivals

Amicus Finally Wins FDA Nod, Will Price Fabry Drug Below Rivals

Source: 
Xconomy
snippet: 

he FDA has approved a new treatment for Fabry disease, a decision that represents the end of a winding, more than decade-long saga for the drug’s developer, Amicus Therapeutics. Its long journey also highlights how drug approval in the U.S. has changed just in the last two years, thanks to new FDA leadership and recent legislation that has put patient voices front and center.